According to The Washington Post, recent results from a study show great news for women diagnosed with early-stage breast cancer. The news is that the majority of these women will…
Researchers have found that inhibiting an enzyme called heparanase can significantly reduce the growth of mesothelioma in mouse models. The full article can be found here, at the American Technion…
According to Bloomberg, there’s a new big fish in the medical technology pond. Crispr Therapeutics AG jumped in value, multiplied by six, and landed at $3 billion. How is that…
A recently published study has found that a protein the in blood, called CC16, can predict lung disease progression in patients with systemic sclerosis. High levels of the protein are…
Efficiency is one of the great success of modern computers. When it comes to sifting through large quantities of data or recognizing patterns, for instance, computers are several magnitudes better…
A new clinical trial aims to be the first treatment for mitochondrial disease to be granted FDA approval. Whether or not the trial results in a landmark treatment, it is…
Why is non-adherence still a problem for many hemophilia patients? There’s a very simple answer here: it’s because hemophilia can be difficult to manage and hard to live with. There’s…
As a 26-year-old working mother, all of life seemed in place. A rewarding job, a precious baby, and a supportive husband filled the hours and made for great memories. Days…
During the holy month of Ramadan, it is common for followers of the Muslim faith to observe a fast. Patients with chronic kidney disease, however, may face complications with this…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
